ESC 365 - Is hs-troponin alone really enough?

ACVC Premium Access

Is hs-troponin alone really enough?

Session: Challenges and controversies in acute coronary syndromes in 2022

Topic: Acute Coronary Syndromes

Speaker: Professor A. Jaffe (Rochester, US)

Event: ESC Acute CardioVascular Care 2022

Congress Session

About the speaker

Professor Allan Jaffe

Mayo Clinic, Rochester (United States of America)

5 presentations

0 follower

3 more presentations in this session

One week of triple therapy for all?

Speaker: Professor S. Kristensen (Aarhus, DK)

Acute coronary syndromes in the elderly: same, same, but different?

Speaker: Doctor I. Cavallari (Rome, IT)

Challenges and contoversies in acute coronary syndromes in 2022 -discussion.

Access the full session

Challenges and controversies in acute coronary syndromes in 2022

Speakers: Professor A. Jaffe, Professor S. Kristensen, Doctor I. Cavallari

About the event

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Congress

Related content

ACVC Premium Access

Acute decompensated heart failure and acute pulmonary edema.

19 March 2022

ESC Premium Access

The HEP-COVID Trial

27 August 2021

ESC Premium Access

Major arterial and venous thromboembolic complications in patients with covid-19

27 August 2021

This platform is supported by